Frequent expression of P‐glycoprotein/MDR1 by nasal T‐cell lymphoma cells

Cancer

Volumn 76, Issue 11, 1995, Pages 2351-2356

  Yamaguchi, Motoko ^a   Kita, Kenkichi ^a   Miwa, Hiroshi ^a   Nishii, Kazuhiro ^a   Oka, Kouji ^a   Ohno, Toshiyuki ^a   Shirakawa, Shigeru ^a   Fukumoto, Manabu ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

lethal midline granuloma; multidrug resistant gene 1 (MDR1); multidrug resistant gene 3 (MDR3); nasal lymphoma; natural killer cell; non Hodgkin's lymphoma; P glycoprotein; Rhodamine 123

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MULTIDRUG RESISTANCE; NOSE CANCER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOMA, LETHAL MIDLINE; HUMAN; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; NOSE DISEASES; NOSE NEOPLASMS; P-GLYCOPROTEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RHODAMINE 123; RHODAMINES; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 0028791591     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1     Document Type: Article

References (28)

1. Midline malignant reticulosis (so‐called lethal midline granuloma)
2. Primary lymphoma of the nose including a relationship to lethal midline granuloma
3. Most nasal/nasopharyngeal lymphomas are peripheral T‐cell neoplasms
4. Presence of Epstein‐Barr virus DNA in nasal lymphomas of B and 'T' cell type
5. Nasal T‐cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein‐Barr virus
6. Discordant reaction of Leu4 and rabbit anti‐human CD3 in sinonasal 'T'‐cell lymphoma
7. Radiation therapy of midline granuloma
8. Non‐Hodgkin's lymphomas of nasal cavity and paranasal sinuses: An immunohistochemical study
9. Internal duplication and homology with bacterial transport proteins in the mdr1 (P‐glycoprotein) gene from multidrug‐resistant human cells
10. Isolation of human mdr DNA sequences amplified in multidrug‐resistant KB carcinoma cells
11. Multidrug resistance in human cancer
12. The multidrug transporter, a double‐edged sword
13. Sequence of mdr3 cDNA encoding a human P‐glycoprotein
14. Functional expression of P‐glycoprotein encoded by the mouse mdr3 gene in yeast cells
15. The non‐Hodgkin's lymphoma pathologic classification project. National cancer institute sponsored study of classifications of non‐Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
16. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines
17. Efficient inhibition of P‐glycoprotein‐mediated multidrug resistance with a monoclonal antibody
18. Amplification of RNA
19. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia
20. p53 gene mutation in B‐cell chronic leukemia is associated with drug resistance and is independent of MDR1/ MDR3 gene expression
21. Molecular structure of the human cytoplasmicβ‐actin gene: interspecies homology of sequences in the introns
22. Expression and activity of P‐glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
23. Expression and activity of the multidrug resistance P‐glycoprotein in human peripheral blood lymphocytes
24. S100‐positive histiocytes in T‐cell‐dependent area in human lymph nodes express P‐glycoprotein
25. P‐glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high‐dose verapamil
26. Immunohistochemical identification of P‐glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas
27. Expression of mdr1 and mdr3 multidrug‐resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine
28. Expression of multidrug resistance P‐glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte‐proliferative disorders